Highlander Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50
Closed -$1K 646
2022
Q3
$1K Hold
50
﹤0.01% 602
2022
Q2
$2K Hold
50
﹤0.01% 591
2022
Q1
$4K Hold
50
﹤0.01% 557
2021
Q4
$5K Hold
50
﹤0.01% 527
2021
Q3
$6K Hold
50
﹤0.01% 509
2021
Q2
$8K Hold
50
﹤0.01% 509
2021
Q1
$9K Sell
50
-150
-75% -$34.8K ﹤0.01% 507
2020
Q4
$40K Sell
200
-50
-20% -$10.2K 0.02% 311
2020
Q3
$55K Buy
+250
New +$52.9K 0.03% 266

Other funds holding TDOC

Highlander Capital Management's TDOC Position: Q4 2022 in Review

Highlander Capital Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 50 shares — an estimated $1K sold.

Highlander Capital Management first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $55K in Q3 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Highlander Capital Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Highlander Capital Management sold 50 Teladoc Health shares in Q4 2022, an estimated $1K.
  • Highlander Capital Management first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Highlander Capital Management's Teladoc Health position peaked at $55K in Q3 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Highlander Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.